Stories by Dana
Three Los Angeles business schools rated among the nation’s best graduate MBA programs, with each moving up in rank this year, according to Bloomberg Businessweek’s 2017 list of Best Business Schools.
GoForward brings tech-heavy service plan backed by $100 million in VC money
It’s billed as “Apple store meets doctor’s office,” its chief executive hails from Google and its newest office opened last week in Westfield’s Century City mall instead of a medical building.
HEALTH CARE: 58,000 jobs here; Bay Area still top market in state
Report moves L.A. up on rankings of life sciences employment hubs.
HEALTH CARE: Trim of 200 jobs, prime lab available
Biotech pioneer to shut Santa Monica lab.
Employment in the Los Angeles life sciences sector has surpassed that of San Diego, vaulting the region to No. 2 in the Golden State, according to an industry report.
Catasys Inc., which provides predictive analytics to reduce the cost of health insurance claims, reported third-quarter net income of $1.2 million, down 11 percent from the same period a year ago.
Puma Biotechnology’s flagship drug has been shown to reduce the risk of breast cancer, recurring disease or death in women who have taken it five years, according to a new study.
Special Report: Overview of our annual 100 fastest-growing private companies.
Two leading L.A. biotech companies reported third-quarter losses Thursday, while announcing increased sales of cancer treatments.
Community Medical Center Long Beach announced this week it would shutter its ER and acute care services within 18 months because the nearly century-old hospital can’t meet state earthquake safety standards.
The LAC+USC Medical Center in Boyle Heights on Oct. 27 unveiled a $4.6 million renovation of a half-century-old ambulatory care clinic, the largest in Los Angeles County.
Researchers at Children’s Hospital Los Angeles will lead a $4.8 million study to engineer T-cells to battle toxic viruses in children.
Months after the troubled Fortune 500 insurance company announced a wholesale makeover, Molina Healthcare Inc. reported a $97 million third-quarter loss.
Puma Biotechnology has received up to $100 million in term loan funding to support the research and sale of a breast cancer drug approved this summer.
Science center funded by $50 million donation from Michelson family
USC is betting big on biotech, dedicating the university’s largest campus building to research biosciences.
Beset by seismic costs, Pacific Alliance Medical Center to end 157-year run in Chinatown
L.A.’s oldest hospital is expected to close in December.
Beset by costs, Pacific Alliance Medical Center in Chinatown ends 157-year run.
Pacific Alliance Medical Center, the oldest hospital in Los Angeles, with roots predating the Civil War, will close in December, laying off 640 workers.
Konica Minolta’s $1 billion purchase of Ambry Genetics, which closed today, was shepherded by West L.A.’s Intrepid Investment Bankers, company officials announced.
Neural Analytics Inc., a medical device maker based in Rancho Park, has been awarded a $10 million contract by the U.S. Army to help develop a portable kit to assess combat-related traumatic brain injuries.
The National Institutes of Health has awarded Children’s Hospital Los Angeles $1.7 million to research the brains of premature babies.
Finian Tan eyes biosciences, $92 million private capital spend in California, N.Y.
The $40-billion life sciences market in Los Angeles could soon get a boost from Singapore financier Finian Tan.
Tie-in with AltaMed boosts market share, brings care to range of neighborhoods.
Children’s Hospital of Los Angeles expands with collaborations.
How a 2-year-old effort by USC’s Keck School of Medicine is spurring a digital health hub in the Los Angeles area.
The U.S. Food and Drug Administration has approved a cancer therapy developed by Kite Pharma that involves rejiggering a patient’s immune cells to kill cancer.
A quarter of patients admitted to Los Angeles County hospitals are readmitted within 30 days, the highest rate in the state for any county with more than one hospital, according to a recent study.
An East Hollywood nursing home that has been the subject of a flood of complaints for patient abuse and neglect will close this week, with nearly 130 workers to lose their jobs.
Eos Biosciences, a Los Angeles nanomedicines company affiliated with Cedars-Sinai Medical Center, has obtained a patent for a drug delivery platform aimed toward breast cancer.
Two leading Los Angeles medical institutes have developed a liquid biopsy for a cancer of the retina that can blind or kill children younger than 5 years old, researchers announced Monday.
Brentwood-based CytRx Corp. will team up with Patrick Soon-Shiong’s NantCell Inc. of Culver City to test a late-stage cancer drug, CytRx announced Thursday. The company also asked investors Tuesday to approve a one-for-six reverse stock split to continue the company’s listing on the Nasdaq exchange, according to Securities and Exchange Commission filings.
Molina Healthcare Inc. named Joseph M. Zubretsky chief executive Tuesday after a summer that included a layoff announcement and c-suite shakeup.
Children’s Hospital Los Angeles has received a nearly $9 million federal grant to research a new treatment for infants born with severe combined immunodeficiency, commonly known as “bubble boy” syndrome.
ImaginAb Inc., an Inglewood immune-oncology imaging company, has teamed up with a San Francisco cancer institute to launch human clinical trials after receiving $8 million in new funding.
Herbalife Ltd. said Friday it had closed its $600 million stock buyback. The announcement, coupled with the anticipation of further buybacks, sent shares up by 10 percent in early trading.
Industry leaders want more venture capital to flow toward area companies
Their pitches to investors promised breakthroughs in bioscience – and potential windfalls from new drugs, immunotherapies and digital monitoring of medical patients.
New labs seen as fuel for L.A. biotech
Ready-to-use wet labs for early-stage biotech firms are popping up across Los Angeles County.
Pharmaceutical firm raises cash for drug trials; business accelerator gets federal contract; Cherin Group gambles on sports companies.
Researchers at City of Hope National Medical Center have won a $13 million grant to fund a clinical trial employing CAR-T cell immunotherapy to kill brain cancer.
Ritter Pharmaceuticals Inc., a Century City biotech company that develops therapies for gastrointestinal diseases, raised $23 million to fund a Phase 3 clinical trial for its lactose intolerance treatment.
Petnet Inc., a privately held Los Angeles company that sells automatic pet feeders for cats and dogs, has received a $3.75 million cash infusion, according to an SEC filing.
NantKwest Inc., part of billionaire Patrick Soon-Shiong’s biotech empire, has launched a clinical trial for its immunotherapy treatment that employs “natural killer cells” to combat cancer.
$87 million in giving failed to score among the top 10 regions in seven out of eight sectors
A report from Fidelity Investments suggests that Los Angeles donors give most to education charities, human services and religious causes.
Partnership with community colleges urged
Industries across Greater Los Angeles will face a steep shortage of middle-skill workers in fields from health care to computer technology unless community colleges can match student skills with employers, according to a study released Tuesday.
Chapman University’s science center books $20 million from the W.M. Keck Foundation.
The W.M. Keck Foundation donated $20 million to Chapman University for a new center for science and engineering, its largest and most expensive building on campus, the institutions announced Thursday.
The Conrad N. Hilton Foundation has awarded $8.5 million over three years to support a Home for Good initiative at the United Way of Los Angeles to help end chronic homelessness in Los Angeles County.